General Information of Disease (ID: DISSLH1X)

Disease Name Oesophagogastric junction cancer
Disease Class 2B71: Oesophagogastric junction cancer
Disease Hierarchy
DIS01GPL: Grass pollen hypersensitivity
DISSLH1X: Oesophagogastric junction cancer
ICD Code
ICD-11
ICD-11: 2B71.Z

Drug-Interaction Atlas (DIA) of This Disease

Drug-Interaction Atlas (DIA)
This Disease is Treated as An Indication in 2 Clinical Trial Drug(s)
Drug Name Drug ID Highest Status Drug Type REF
DKN-01 DMOHT5V Phase 2 Antibody [1]
ZW25 DMRLZA1 Phase 2 Antibody [2]
------------------------------------------------------------------------------------

Molecular Interaction Atlas (MIA) of This Disease

Molecular Interaction Atlas (MIA)

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
2 ClinicalTrials.gov (NCT04224272) A Study of ZW25 (Zanidatamab) With Palbociclib Plus Fulvestrant in Patients With HER2+/HR+ Advanced Breast Cancer. U.S. National Institutes of Health.